Title : Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.

Pub. Date : 2019 Jan

PMID : 30157131






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinical studies indicate that cannabidiol (CBD), the primary nonaddictive component of cannabis that interacts with the serotonin (5-HT)1A receptor, may possess analgesic and anxiolytic effects. Cannabidiol 5-hydroxytryptamine receptor 1A Rattus norvegicus
2 Clinical studies indicate that cannabidiol (CBD), the primary nonaddictive component of cannabis that interacts with the serotonin (5-HT)1A receptor, may possess analgesic and anxiolytic effects. Cannabidiol 5-hydroxytryptamine receptor 1A Rattus norvegicus
3 Repeated treatment with CBD (5 mg/kg/day, subcutaneously [s.c.], for 7 days) increased 5-HT firing through desensitization of 5-HT1A receptors. Cannabidiol 5-hydroxytryptamine receptor 1A Rattus norvegicus
4 Overall, repeated treatment with low-dose CBD induces analgesia predominantly through TRPV1 activation, reduces anxiety through 5-HT1A receptor activation, and rescues impaired 5-HT neurotransmission under neuropathic pain conditions. Cannabidiol 5-hydroxytryptamine receptor 1A Rattus norvegicus